医学系

検索結果

• Supplementary Material for: Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion

  Takata, Y. (作成者), Nitta, Y. (作成者), Miyakoshi, A. (作成者) & Hayashi, A. (作成者), Karger Publishers, 2018

  DOI: 10.6084/m9.figshare.6620360.v1, https://karger.figshare.com/articles/Supplementary_Material_for_Retinal_Endovascular_Surgery_with_Tissue_Plasminogen_Activator_Injection_for_Central_Retinal_Artery_Occlusion/6620360/1

  データセット

• Supplementary Material for: Relationship of atezolizumab plus bevacizumab treatment with muscle volume loss in unresectable hepatocellular carcinoma patients– multicenter analysis

  Hiraoka, A. (寄稿者), Kumada, T. (寄稿者), Tada, T. (寄稿者), Hirooka, M. (寄稿者), Kariyama, K. (寄稿者), Tani, J. (寄稿者), Atsukawa, M. (寄稿者), Takaguchi, K. (寄稿者), Itobayashi, E. (寄稿者), Fukunishi, S. (寄稿者), Tsuji, K. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Ogawa, C. (寄稿者), Nishimura, T. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Shimada, N. (寄稿者), Kawata, K. (寄稿者), Naganuma, A. (寄稿者), Kaibori, M. (寄稿者), Tanaka, T. (寄稿者), Ohama, H. (寄稿者), Nouso, K. (寄稿者), Morishita, A. (寄稿者), Tsutsui, A. (寄稿者), Nagano, T. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Koizumi, Y. (寄稿者), Nakamura, S. (寄稿者), Joko, K. (寄稿者), Iijima, H. (寄稿者), Kosaka, H. (寄稿者), Hiasa, Y. (寄稿者) & Kudo, M. (寄稿者), Karger Publishers, 2022

  DOI: 10.6084/m9.figshare.21695111.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Relationship_of_atezolizumab_plus_bevacizumab_treatment_with_muscle_volume_loss_in_unresectable_hepatocellular_carcinoma_patients_multicenter_analysis/21695111/1

  データセット

• Supplementary Material for: Relationship of atezolizumab plus bevacizumab treatment with muscle volume loss in unresectable hepatocellular carcinoma patients– multicenter analysis

  Hiraoka, A. (寄稿者), Kumada, T. (寄稿者), Tada, T. (寄稿者), Hirooka, M. (寄稿者), Kariyama, K. (寄稿者), Tani, J. (寄稿者), Atsukawa, M. (寄稿者), Takaguchi, K. (寄稿者), Itobayashi, E. (寄稿者), Fukunishi, S. (寄稿者), Tsuji, K. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Ogawa, C. (寄稿者), Nishimura, T. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Shimada, N. (寄稿者), Kawata, K. (寄稿者), Naganuma, A. (寄稿者), Kaibori, M. (寄稿者), Tanaka, T. (寄稿者), Ohama, H. (寄稿者), Nouso, K. (寄稿者), Morishita, A. (寄稿者), Tsutsui, A. (寄稿者), Nagano, T. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Koizumi, Y. (寄稿者), Nakamura, S. (寄稿者), Joko, K. (寄稿者), Iijima, H. (寄稿者), Kosaka, H. (寄稿者), Hiasa, Y. (寄稿者) & Kudo, M. (寄稿者), Karger Publishers, 2022

  DOI: 10.6084/m9.figshare.21695111, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Relationship_of_atezolizumab_plus_bevacizumab_treatment_with_muscle_volume_loss_in_unresectable_hepatocellular_carcinoma_patients_multicenter_analysis/21695111

  データセット

• Supplementary Material for: Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib

  Hiraoka, A. (作成者), Kumada, T. (作成者), Fukunishi, S. (作成者), Atsukawa, M. (作成者), Hirooka, M. (作成者), Tsuji, K. (作成者), Ishikawa, T. (作成者), Takaguchi, K. (作成者), Kariyama, K. (作成者), Itobayashi, E. (作成者), Tajiri, K. (作成者), Shimada, N. (作成者), Shibata, H. (作成者), Ochi, H. (作成者), Tada, T. (作成者), Toyoda, H. (作成者), Yokohama, K. (作成者), Nouso, K. (作成者), Tsutsui, A. (作成者), Nagano, T. (作成者), Itokawa, N. (作成者), Hayama, K. (作成者), Arai, T. (作成者), Imai, M. (作成者), Joko, K. (作成者), Koizumi, Y. (作成者), Hiasa, Y. (作成者), Michitaka, K. (作成者) & Kudo, M. (作成者), Karger Publishers, 2019

  DOI: 10.6084/m9.figshare.10000382, https://karger.figshare.com/articles/Supplementary_Material_for_Post-Progression_Treatment_Eligibility_of_Unresectable_Hepatocellular_Carcinoma_Patients_Treated_with_Lenvatinib/10000382

  データセット

• Supplementary Material for: Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib

  Hiraoka, A. (作成者), Kumada, T. (作成者), Fukunishi, S. (作成者), Atsukawa, M. (作成者), Hirooka, M. (作成者), Tsuji, K. (作成者), Ishikawa, T. (作成者), Takaguchi, K. (作成者), Kariyama, K. (作成者), Itobayashi, E. (作成者), Tajiri, K. (作成者), Shimada, N. (作成者), Shibata, H. (作成者), Ochi, H. (作成者), Tada, T. (作成者), Toyoda, H. (作成者), Yokohama, K. (作成者), Nouso, K. (作成者), Tsutsui, A. (作成者), Nagano, T. (作成者), Itokawa, N. (作成者), Hayama, K. (作成者), Arai, T. (作成者), Imai, M. (作成者), Joko, K. (作成者), Koizumi, Y. (作成者), Hiasa, Y. (作成者), Michitaka, K. (作成者) & Kudo, M. (作成者), Karger Publishers, 2019

  DOI: 10.6084/m9.figshare.10000382.v1, https://karger.figshare.com/articles/Supplementary_Material_for_Post-Progression_Treatment_Eligibility_of_Unresectable_Hepatocellular_Carcinoma_Patients_Treated_with_Lenvatinib/10000382/1

  データセット

• Supplementary Material for: Objective response and progression free survival contribute to prolong overall survival in atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma.

  Tajiri, K. (寄稿者), Tsukada, K. (寄稿者), Tokimitsu, Y. (寄稿者), Motofuji, Y. (寄稿者), Kawai, K. (寄稿者), Muraishi, N. (寄稿者), Murayama, A. (寄稿者), Hayashi, Y. (寄稿者), Shimizu, Y. (寄稿者) & Yasuda, I. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.24080436, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Objective_response_and_progression_free_survival_contribute_to_prolong_overall_survival_in_atezolizumab_plus_bevacizumab_treatment_for_unresectable_hepatocellular_carcinoma_/24080436

  データセット

• Supplementary Material for: Objective response and progression free survival contribute to prolong overall survival in atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma.

  Tajiri, K. (寄稿者), Tsukada, K. (寄稿者), Tokimitsu, Y. (寄稿者), Motofuji, Y. (寄稿者), Kawai, K. (寄稿者), Muraishi, N. (寄稿者), Murayama, A. (寄稿者), Hayashi, Y. (寄稿者), Shimizu, Y. (寄稿者) & Yasuda, I. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.24080436.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Objective_response_and_progression_free_survival_contribute_to_prolong_overall_survival_in_atezolizumab_plus_bevacizumab_treatment_for_unresectable_hepatocellular_carcinoma_/24080436/1

  データセット

• Supplementary Material for: Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma

  Hiraoka, A. (作成者), Kumada, T. (作成者), Tada, T. (作成者), Fukunishi, S. (作成者), Atsukawa, M. (作成者), Hirooka, M. (作成者), Tsuji, K. (作成者), Ishikawa, T. (作成者), Takaguchi, K. (作成者), Kariyama, K. (作成者), Itobayashi, E. (作成者), Tajiri, K. (作成者), Shimada, N. (作成者), Shibata, H. (作成者), Ochi, H. (作成者), Kawata, K. (作成者), Toyoda, H. (作成者), Ohama, H. (作成者), Tsutsui, A. (作成者), Itokawa, N. (作成者), Hayama, K. (作成者), Arai, T. (作成者), Imai, M. (作成者), Nakamura, S. (作成者), Michitaka, K. (作成者), Hiasa, Y. (作成者) & Kudo, M. (作成者), Karger Publishers, 2020

  DOI: 10.6084/m9.figshare.11898228, https://karger.figshare.com/articles/Supplementary_Material_for_Nutritional_Index_as_Prognostic_Indicator_in_Patients_Receiving_Lenvatinib_Treatment_for_Unresectable_Hepatocellular_Carcinoma/11898228

  データセット

• Supplementary Material for: Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma

  Hiraoka, A. (作成者), Kumada, T. (作成者), Tada, T. (作成者), Fukunishi, S. (作成者), Atsukawa, M. (作成者), Hirooka, M. (作成者), Tsuji, K. (作成者), Ishikawa, T. (作成者), Takaguchi, K. (作成者), Kariyama, K. (作成者), Itobayashi, E. (作成者), Tajiri, K. (作成者), Shimada, N. (作成者), Shibata, H. (作成者), Ochi, H. (作成者), Kawata, K. (作成者), Toyoda, H. (作成者), Ohama, H. (作成者), Tsutsui, A. (作成者), Itokawa, N. (作成者), Hayama, K. (作成者), Arai, T. (作成者), Imai, M. (作成者), Nakamura, S. (作成者), Michitaka, K. (作成者), Hiasa, Y. (作成者) & Kudo, M. (作成者), Karger Publishers, 2020

  DOI: 10.6084/m9.figshare.11898228.v1, https://karger.figshare.com/articles/Supplementary_Material_for_Nutritional_Index_as_Prognostic_Indicator_in_Patients_Receiving_Lenvatinib_Treatment_for_Unresectable_Hepatocellular_Carcinoma/11898228/1

  データセット

• Supplementary Material for: Maternal dietary vitamin D intake during pregnancy is associated with allergic disease symptoms in children at 3 years old: the Japan Environment and Children’s Study

  Shimizu, M. (寄稿者), Kato, T. (寄稿者), Wada, T. (寄稿者), Murakami, S. (寄稿者), Ito, Y. (寄稿者), Itazawa, T. (寄稿者), Adachi, Y. S. (寄稿者), Tsuchida, A. (寄稿者), Matsumura, K. (寄稿者), Hamazaki, K. (寄稿者) & Inadera, H. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.23821215, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Maternal_dietary_vitamin_D_intake_during_pregnancy_is_associated_with_allergic_disease_symptoms_in_children_at_3_years_old_the_Japan_Environment_and_Children_s_Study/23821215

  データセット

• Supplementary Material for: Maternal dietary vitamin D intake during pregnancy is associated with allergic disease symptoms in children at 3 years old: the Japan Environment and Children’s Study

  Shimizu, M. (寄稿者), Kato, T. (寄稿者), Wada, T. (寄稿者), Murakami, S. (寄稿者), Ito, Y. (寄稿者), Itazawa, T. (寄稿者), Adachi, Y. S. (寄稿者), Tsuchida, A. (寄稿者), Matsumura, K. (寄稿者), Hamazaki, K. (寄稿者) & Inadera, H. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.23821215.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Maternal_dietary_vitamin_D_intake_during_pregnancy_is_associated_with_allergic_disease_symptoms_in_children_at_3_years_old_the_Japan_Environment_and_Children_s_Study/23821215/1

  データセット

• Supplementary Material for: Lenvatinib as second-line treatment after atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma –clinical results show importance of hepatic reserve function

  Hiraoka, A. (寄稿者), Kumada, T. (寄稿者), Tada, T. (寄稿者), Hirooka, M. (寄稿者), Kariyama, K. (寄稿者), Tani, J. (寄稿者), Atsukawa, M. (寄稿者), Takaguchi, K. (寄稿者), Itobayashi, E. (寄稿者), Fukunishi, S. (寄稿者), Tsuji, K. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Ogawa, C. (寄稿者), Nishimura, T. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Shimada, N. (寄稿者), Kawata, K. (寄稿者), Naganuma, A. (寄稿者), Kosaka, H. (寄稿者), Matono, T. (寄稿者), Kuroda, H. (寄稿者), Yata, Y. (寄稿者), Ohama, H. (寄稿者), Tada, F. (寄稿者), Nouso, K. (寄稿者), Morishita, A. (寄稿者), Tsutsui, A. (寄稿者), Nagano, T. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Yokohama, K. (寄稿者), Imai, M. (寄稿者), Koizumi, Y. (寄稿者), Nakamura, S. (寄稿者), Iijima, H. (寄稿者), Kaibori, M. (寄稿者) & Hiasa, Y. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.23500869.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Lenvatinib_as_second-line_treatment_after_atezolizumab_plus_bevacizumab_for_unresectable_hepatocellular_carcinoma_clinical_results_show_importance_of_hepatic_reserve_function/23500869/1

  データセット

• Supplementary Material for: Lenvatinib as second-line treatment after atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma –clinical results show importance of hepatic reserve function

  Hiraoka, A. (寄稿者), Kumada, T. (寄稿者), Tada, T. (寄稿者), Hirooka, M. (寄稿者), Kariyama, K. (寄稿者), Tani, J. (寄稿者), Atsukawa, M. (寄稿者), Takaguchi, K. (寄稿者), Itobayashi, E. (寄稿者), Fukunishi, S. (寄稿者), Tsuji, K. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Ogawa, C. (寄稿者), Nishimura, T. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Shimada, N. (寄稿者), Kawata, K. (寄稿者), Naganuma, A. (寄稿者), Kosaka, H. (寄稿者), Matono, T. (寄稿者), Kuroda, H. (寄稿者), Yata, Y. (寄稿者), Ohama, H. (寄稿者), Tada, F. (寄稿者), Nouso, K. (寄稿者), Morishita, A. (寄稿者), Tsutsui, A. (寄稿者), Nagano, T. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Yokohama, K. (寄稿者), Imai, M. (寄稿者), Koizumi, Y. (寄稿者), Nakamura, S. (寄稿者), Iijima, H. (寄稿者), Kaibori, M. (寄稿者) & Hiasa, Y. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.23500869, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Lenvatinib_as_second-line_treatment_after_atezolizumab_plus_bevacizumab_for_unresectable_hepatocellular_carcinoma_clinical_results_show_importance_of_hepatic_reserve_function/23500869

  データセット

• Supplementary Material for: Incidence and predictors of esophagogastric varices bleeding in patients with hepatocellular carcinoma in lenvatinib

  Iavarone, M. (寄稿者), Alimenti, E. (寄稿者), Tada, T. (寄稿者), Shimose, S. (寄稿者), Suda, G. (寄稿者), Yoo, C. (寄稿者), Soldà, C. (寄稿者), Piscaglia, F. (寄稿者), Tosetti, G. (寄稿者), Marra, F. (寄稿者), Vivaldi, C. (寄稿者), Conti, F. (寄稿者), Schirripa, M. (寄稿者), Iwamoto, H. (寄稿者), Sho, T. (寄稿者), Lee, S. H. (寄稿者), Rizzato, M. D. (寄稿者), Tonnini, M. (寄稿者), Rimini, M. (寄稿者), Campani, C. (寄稿者), Masi, G. (寄稿者), Foschi, F. (寄稿者), Bruccoleri, M. (寄稿者), Kawaguchi, T. (寄稿者), Kumada, T. (寄稿者), Hiraoka, A. (寄稿者), Atsukawa, M. (寄稿者), Fukunishi, S. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Kawata, K. (寄稿者), Tada, F. (寄稿者), Ohama, H. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Naganuma, A. (寄稿者), Casadei-Gardini, A. (寄稿者) & Lampertico, P. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.24138684, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Incidence_and_predictors_of_esophagogastric_varices_bleeding_in_patients_with_hepatocellular_carcinoma_in_lenvatinib/24138684

  データセット

• Supplementary Material for: Incidence and predictors of esophagogastric varices bleeding in patients with hepatocellular carcinoma in lenvatinib

  Iavarone, M. (寄稿者), Alimenti, E. (寄稿者), Tada, T. (寄稿者), Shimose, S. (寄稿者), Suda, G. (寄稿者), Yoo, C. (寄稿者), Soldà, C. (寄稿者), Piscaglia, F. (寄稿者), Tosetti, G. (寄稿者), Marra, F. (寄稿者), Vivaldi, C. (寄稿者), Conti, F. (寄稿者), Schirripa, M. (寄稿者), Iwamoto, H. (寄稿者), Sho, T. (寄稿者), Lee, S. H. (寄稿者), Rizzato, M. D. (寄稿者), Tonnini, M. (寄稿者), Rimini, M. (寄稿者), Campani, C. (寄稿者), Masi, G. (寄稿者), Foschi, F. (寄稿者), Bruccoleri, M. (寄稿者), Kawaguchi, T. (寄稿者), Kumada, T. (寄稿者), Hiraoka, A. (寄稿者), Atsukawa, M. (寄稿者), Fukunishi, S. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Kawata, K. (寄稿者), Tada, F. (寄稿者), Ohama, H. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Naganuma, A. (寄稿者), Casadei-Gardini, A. (寄稿者) & Lampertico, P. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.24138987, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Incidence_and_predictors_of_esophagogastric_varices_bleeding_in_patients_with_hepatocellular_carcinoma_in_lenvatinib/24138987

  データセット

• Supplementary Material for: Incidence and predictors of esophagogastric varices bleeding in patients with hepatocellular carcinoma in lenvatinib

  Iavarone, M. (寄稿者), Alimenti, E. (寄稿者), Tada, T. (寄稿者), Shimose, S. (寄稿者), Suda, G. (寄稿者), Yoo, C. (寄稿者), Soldà, C. (寄稿者), Piscaglia, F. (寄稿者), Tosetti, G. (寄稿者), Marra, F. (寄稿者), Vivaldi, C. (寄稿者), Conti, F. (寄稿者), Schirripa, M. (寄稿者), Iwamoto, H. (寄稿者), Sho, T. (寄稿者), Lee, S. H. (寄稿者), Rizzato, M. D. (寄稿者), Tonnini, M. (寄稿者), Rimini, M. (寄稿者), Campani, C. (寄稿者), Masi, G. (寄稿者), Foschi, F. (寄稿者), Bruccoleri, M. (寄稿者), Kawaguchi, T. (寄稿者), Kumada, T. (寄稿者), Hiraoka, A. (寄稿者), Atsukawa, M. (寄稿者), Fukunishi, S. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Kawata, K. (寄稿者), Tada, F. (寄稿者), Ohama, H. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Naganuma, A. (寄稿者), Casadei-Gardini, A. (寄稿者) & Lampertico, P. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.24138684.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Incidence_and_predictors_of_esophagogastric_varices_bleeding_in_patients_with_hepatocellular_carcinoma_in_lenvatinib/24138684/1

  データセット

• Supplementary Material for: Incidence and predictors of esophagogastric varices bleeding in patients with hepatocellular carcinoma in lenvatinib

  Iavarone, M. (寄稿者), Alimenti, E. (寄稿者), Tada, T. (寄稿者), Shimose, S. (寄稿者), Suda, G. (寄稿者), Yoo, C. (寄稿者), Soldà, C. (寄稿者), Piscaglia, F. (寄稿者), Tosetti, G. (寄稿者), Marra, F. (寄稿者), Vivaldi, C. (寄稿者), Conti, F. (寄稿者), Schirripa, M. (寄稿者), Iwamoto, H. (寄稿者), Sho, T. (寄稿者), Lee, S. H. (寄稿者), Rizzato, M. D. (寄稿者), Tonnini, M. (寄稿者), Rimini, M. (寄稿者), Campani, C. (寄稿者), Masi, G. (寄稿者), Foschi, F. (寄稿者), Bruccoleri, M. (寄稿者), Kawaguchi, T. (寄稿者), Kumada, T. (寄稿者), Hiraoka, A. (寄稿者), Atsukawa, M. (寄稿者), Fukunishi, S. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Kawata, K. (寄稿者), Tada, F. (寄稿者), Ohama, H. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Naganuma, A. (寄稿者), Casadei-Gardini, A. (寄稿者) & Lampertico, P. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.24138687, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Incidence_and_predictors_of_esophagogastric_varices_bleeding_in_patients_with_hepatocellular_carcinoma_in_lenvatinib/24138687

  データセット

• Supplementary Material for: Incidence and predictors of esophagogastric varices bleeding in patients with hepatocellular carcinoma in lenvatinib

  Iavarone, M. (寄稿者), Alimenti, E. (寄稿者), Tada, T. (寄稿者), Shimose, S. (寄稿者), Suda, G. (寄稿者), Yoo, C. (寄稿者), Soldà, C. (寄稿者), Piscaglia, F. (寄稿者), Tosetti, G. (寄稿者), Marra, F. (寄稿者), Vivaldi, C. (寄稿者), Conti, F. (寄稿者), Schirripa, M. (寄稿者), Iwamoto, H. (寄稿者), Sho, T. (寄稿者), Lee, S. H. (寄稿者), Rizzato, M. D. (寄稿者), Tonnini, M. (寄稿者), Rimini, M. (寄稿者), Campani, C. (寄稿者), Masi, G. (寄稿者), Foschi, F. (寄稿者), Bruccoleri, M. (寄稿者), Kawaguchi, T. (寄稿者), Kumada, T. (寄稿者), Hiraoka, A. (寄稿者), Atsukawa, M. (寄稿者), Fukunishi, S. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Kawata, K. (寄稿者), Tada, F. (寄稿者), Ohama, H. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Naganuma, A. (寄稿者), Casadei-Gardini, A. (寄稿者) & Lampertico, P. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.24138687.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Incidence_and_predictors_of_esophagogastric_varices_bleeding_in_patients_with_hepatocellular_carcinoma_in_lenvatinib/24138687/1

  データセット

• Supplementary Material for: Incidence and predictors of esophagogastric varices bleeding in patients with hepatocellular carcinoma in lenvatinib

  Iavarone, M. (寄稿者), Alimenti, E. (寄稿者), Tada, T. (寄稿者), Shimose, S. (寄稿者), Suda, G. (寄稿者), Yoo, C. (寄稿者), Soldà, C. (寄稿者), Piscaglia, F. (寄稿者), Tosetti, G. (寄稿者), Marra, F. (寄稿者), Vivaldi, C. (寄稿者), Conti, F. (寄稿者), Schirripa, M. (寄稿者), Iwamoto, H. (寄稿者), Sho, T. (寄稿者), Lee, S. H. (寄稿者), Rizzato, M. D. (寄稿者), Tonnini, M. (寄稿者), Rimini, M. (寄稿者), Campani, C. (寄稿者), Masi, G. (寄稿者), Foschi, F. (寄稿者), Bruccoleri, M. (寄稿者), Kawaguchi, T. (寄稿者), Kumada, T. (寄稿者), Hiraoka, A. (寄稿者), Atsukawa, M. (寄稿者), Fukunishi, S. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Kawata, K. (寄稿者), Tada, F. (寄稿者), Ohama, H. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Naganuma, A. (寄稿者), Casadei-Gardini, A. (寄稿者) & Lampertico, P. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.24138987.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Incidence_and_predictors_of_esophagogastric_varices_bleeding_in_patients_with_hepatocellular_carcinoma_in_lenvatinib/24138987/1

  データセット

• Supplementary Material for: Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma

  Hiraoka, A. (作成者), Kumada, T. (作成者), Atsukawa, M. (作成者), Hirooka, M. (作成者), Tsuji, K. (作成者), Ishikawa, T. (作成者), Takaguchi, K. (作成者), Kariyama, K. (作成者), Itobayashi, E. (作成者), Tajiri, K. (作成者), Shimada, N. (作成者), Shibata, H. (作成者), Ochi, H. (作成者), Tada, T. (作成者), Toyoda, H. (作成者), Nouso, K. (作成者), Tsutsui, A. (作成者), Nagano, T. (作成者), Itokawa, N. (作成者), Hayama, K. (作成者), Imai, M. (作成者), Joko, K. (作成者), Tanaka, H. (作成者), Tamai, T. (作成者), Koizumi, Y. (作成者), Hiasa, Y. (作成者), Michitaka, K. (作成者) & Kudo, M. (作成者), Karger Publishers, 2019

  DOI: 10.6084/m9.figshare.8869625, https://karger.figshare.com/articles/Supplementary_Material_for_Important_Clinical_Factors_in_Sequential_Therapy_Including_Lenvatinib_against_Unresectable_Hepatocellular_Carcinoma/8869625

  データセット

• Supplementary Material for: Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma

  Hiraoka, A. (作成者), Kumada, T. (作成者), Atsukawa, M. (作成者), Hirooka, M. (作成者), Tsuji, K. (作成者), Ishikawa, T. (作成者), Takaguchi, K. (作成者), Kariyama, K. (作成者), Itobayashi, E. (作成者), Tajiri, K. (作成者), Shimada, N. (作成者), Shibata, H. (作成者), Ochi, H. (作成者), Tada, T. (作成者), Toyoda, H. (作成者), Nouso, K. (作成者), Tsutsui, A. (作成者), Nagano, T. (作成者), Itokawa, N. (作成者), Hayama, K. (作成者), Imai, M. (作成者), Joko, K. (作成者), Tanaka, H. (作成者), Tamai, T. (作成者), Koizumi, Y. (作成者), Hiasa, Y. (作成者), Michitaka, K. (作成者) & Kudo, M. (作成者), Karger Publishers, 2019

  DOI: 10.6084/m9.figshare.8869625.v1, https://karger.figshare.com/articles/Supplementary_Material_for_Important_Clinical_Factors_in_Sequential_Therapy_Including_Lenvatinib_against_Unresectable_Hepatocellular_Carcinoma/8869625/1

  データセット

• Supplementary Material for: Factors, including clinical trial eligibility, associated with induction of third-line treatment for advanced gastric cancer

  Ando, T. (寄稿者), Hosokawa, A. (寄稿者), Sakumura, M. (寄稿者), Motoo, I. (寄稿者), Kajiura, S. (寄稿者), Hirano, K. (寄稿者), Miwa, T. (寄稿者), Yokota, T. (寄稿者), Nakada, N. (寄稿者), Ueda, Y. (寄稿者), Ueda, A. (寄稿者), Tsukada, K. (寄稿者), Ogawa, K. (寄稿者), Nakaya, A. (寄稿者), Teramoto, A. (寄稿者), Nanjo, S. (寄稿者), Mihara, H. (寄稿者), Fujinami, H. (寄稿者), Fujii, T. (寄稿者) & Yasuda, I. (寄稿者), Karger Publishers, 2022

  DOI: 10.6084/m9.figshare.21101944.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Factors_including_clinical_trial_eligibility_associated_with_induction_of_third-line_treatment_for_advanced_gastric_cancer/21101944/1

  データセット

• Supplementary Material for: Factors, including clinical trial eligibility, associated with induction of third-line treatment for advanced gastric cancer

  Ando, T. (寄稿者), Hosokawa, A. (寄稿者), Sakumura, M. (寄稿者), Motoo, I. (寄稿者), Kajiura, S. (寄稿者), Hirano, K. (寄稿者), Miwa, T. (寄稿者), Yokota, T. (寄稿者), Nakada, N. (寄稿者), Ueda, Y. (寄稿者), Ueda, A. (寄稿者), Tsukada, K. (寄稿者), Ogawa, K. (寄稿者), Nakaya, A. (寄稿者), Teramoto, A. (寄稿者), Nanjo, S. (寄稿者), Mihara, H. (寄稿者), Fujinami, H. (寄稿者), Fujii, T. (寄稿者) & Yasuda, I. (寄稿者), Karger Publishers, 2022

  DOI: 10.6084/m9.figshare.21101944, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Factors_including_clinical_trial_eligibility_associated_with_induction_of_third-line_treatment_for_advanced_gastric_cancer/21101944

  データセット

• Supplementary Material for: Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma

  Hiraoka, A. (作成者), Kumada, T. (作成者), Atsukawa, M. (作成者), Hirooka, M. (作成者), Tsuji, K. (作成者), Ishikawa, T. (作成者), Takaguchi, K. (作成者), Kariyama, K. (作成者), Itobayashi, E. (作成者), Tajiri, K. (作成者), Shimada, N. (作成者), Shibata, H. (作成者), Ochi, H. (作成者), Tada, T. (作成者), Toyoda, H. (作成者), Nouso, K. (作成者), Tsutsui, A. (作成者), Nagano, T. (作成者), Itokawa, N. (作成者), Hayama, K. (作成者), Imai, M. (作成者), Joko, K. (作成者), Koizumi, Y. (作成者), Hiasa, Y. (作成者) & Michitaka, K. (作成者), Karger Publishers, 2019

  DOI: 10.6084/m9.figshare.9746198, https://karger.figshare.com/articles/Supplementary_Material_for_Early_Relative_Change_in_Hepatic_Function_with_Lenvatinib_for_Unresectable_Hepatocellular_Carcinoma/9746198

  データセット

• Supplementary Material for: Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma

  Hiraoka, A. (作成者), Kumada, T. (作成者), Atsukawa, M. (作成者), Hirooka, M. (作成者), Tsuji, K. (作成者), Ishikawa, T. (作成者), Takaguchi, K. (作成者), Kariyama, K. (作成者), Itobayashi, E. (作成者), Tajiri, K. (作成者), Shimada, N. (作成者), Shibata, H. (作成者), Ochi, H. (作成者), Tada, T. (作成者), Toyoda, H. (作成者), Nouso, K. (作成者), Tsutsui, A. (作成者), Nagano, T. (作成者), Itokawa, N. (作成者), Hayama, K. (作成者), Imai, M. (作成者), Joko, K. (作成者), Koizumi, Y. (作成者), Hiasa, Y. (作成者) & Michitaka, K. (作成者), Karger Publishers, 2019

  DOI: 10.6084/m9.figshare.9746198.v1, https://karger.figshare.com/articles/Supplementary_Material_for_Early_Relative_Change_in_Hepatic_Function_with_Lenvatinib_for_Unresectable_Hepatocellular_Carcinoma/9746198/1

  データセット